
08/07/2022
Lung-MAP:
👉 Master Protocol for Lung Cancer
A precision medicine clinical trial for people with advanced non-small cell lung cancer that has continued to grow after treatment. Non-small cell lung cancer makes up about 85% of lung cancer diagnoses.
https://www.cancer.gov/types/lung/research/lung-map
The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.